TickerFacts.

Raphael Pharmaceutical Inc. (RAPH): Shares Outstanding

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

20.18M
As of 2025-12-31
20.18M
As of 2026-06-30
+8.9%
3-year compound annual growth
2020-12-31: 9.46M2021-12-31: 12.97M2022-12-31: 15.62M2023-12-31: 18.50M2024-12-31: 18.70M2025-12-31: 20.18M20.18M
2020-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3120.18M+7.9%2026-03-31, Balance as of period end
2024-12-3118.70M+1.1%2026-03-31, Balance as of period end
2023-12-3118.50M+18.4%2025-03-31, Balance as of period end
2022-12-3115.62M+20.5%2024-03-28, Balance as of period end
2021-12-3112.97Mn/c2023-05-25, Balance as of period end
2020-12-319.46Mn/a2022-03-30, Balance as of period end